1. Home
  2. ADPT vs WIX Comparison

ADPT vs WIX Comparison

Compare ADPT & WIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$28.51

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Logo Wix.com Ltd.

WIX

Wix.com Ltd.

N/A

Current Price

$78.32

Market Cap

3.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ADPT
WIX
Founded
2009
2006
Country
United States
Israel
Employees
624
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.7B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
ADPT
WIX
Price
$28.51
$78.32
Analyst Decision
Strong Buy
Buy
Analyst Count
9
22
Target Price
$17.78
$134.67
AVG Volume (30 Days)
1.8M
1.2M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
63.89
N/A
EPS
N/A
N/A
Revenue
$276,976,000.00
N/A
Revenue This Year
$3.98
$15.80
Revenue Next Year
$22.72
$13.21
P/E Ratio
N/A
$28.86
Revenue Growth
54.77
N/A
52 Week Low
$12.00
$40.00
52 Week High
$28.72
$185.99

Technical Indicators

Market Signals
Indicator
ADPT
WIX
Relative Strength Index (RSI) 73.65 53.59
Support Level $23.73 $75.00
Resistance Level N/A $82.71
Average True Range (ATR) 1.06 4.78
MACD 0.37 -1.02
Stochastic Oscillator 97.40 36.91

Price Performance

Historical Comparison
ADPT
WIX

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years, it has invested heavily and introduced its Wix Studio offering for partners, which are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

Share on Social Networks: